文献速递先天性心脏病外科心外重症与机械循环支持

核游离DNA可预测儿童心胸外科术后不良事件

Nuclear Cell-Free DNA Predicts Adverse Events After Pediatric Cardiothoracic Surgery.
PubMed 文献 · Ann Thorac Surg · 2022-11-01

该前瞻性观察研究纳入116例接受体外循环手术的儿童,在预设围术期时间点检测血浆核游离DNA(ncfDNA)。主要结局为术后心脏骤停或体外膜肺氧合,6/116(5.2%)达成。ncfDNA<20 ng/mL时主要结局风险为2%,ncfDNA>20 ng/mL时为33%(比值比25,CI 3.96-158,P=.001)。ncfDNA升高与无住院天数减少相关(P<.01)。

要点

  • ncfDNA升高与无住院天数减少相关(P<.01)。
  • 作者结论认为术前ncfDNA升高与术后心脏骤停及ECMO强烈相关,需进一步研究验证该技术预测儿童心脏术后并发症的工具价值。

核心结论

  • 术前ncfDNA升高与儿童体外循环心脏术后心脏骤停及体外膜肺氧合强烈相关,需进一步研究验证该技术作为预测儿童心脏术后并发症工具的价值。

研究设计与样本

  • 前瞻性观察研究,纳入116例年龄<18岁且体重>3 kg、接受体外循环手术的儿童,在预设围术期时间点分步采集并处理血浆ncfDNA样本。

主要发现

  • 116例患者中位年龄0.9岁(范围0-17.4岁),中位体重7.8 kg(范围3.2-98 kg)。
  • 主要结局在6/116例(5.2%)中达成。
  • ncfDNA<20 ng/mL时主要结局风险为2%,ncfDNA>20 ng/mL时为33%(比值比25,CI 3.96-158,P=.001)。
  • ncfDNA升高与无住院天数减少相关(P<.01)。

局限性

  • 需进一步研究验证该技术作为预测儿童心脏术后并发症工具的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative risk stratification in cardiac surgery includes patient and procedure factors that are used in clinical decision-making. Despite these tools, unidentified factors contribute to variation in outcomes. Identification of latent physiologic risk factors may strengthen predictive models. Nuclear cell-free DNA (ncfDNA) increases with tissue injury and drops to baseline levels rapidly. The goal of this investigation is to measure and to observe ncfDNA kinetics in children undergoing heart operations with cardiopulmonary bypass (CPB), linking biomarkers, organ dysfunction, and outcomes. METHODS: This is a prospective observational study of 116 children <18 years and >3 kg undergoing operations with CPB. Plasma ncfDNA samples were collected and processed in a stepwise manner at predefined perioperative time points. The primary outcome measure was occurrence of postoperative cardiac arrest or extracorporeal membrane oxygenation. RESULTS: Data were available in 116 patients (median age, 0.9 years [range, 0-17.4 years]; median weight, 7.8 kg [range, 3.2-98 kg]). The primary outcome was met in 6 of 116 (5.2%). Risk of primary outcome was 2% with ncfDNA <20 ng/mL and 33% with ncfDNA >20 ng/mL (odds ratio, 25; CI, 3.96-158; P = .001). Elevated ncfDNA was associated with fewer hospital-free days (P < .01). CONCLUSIONS: This study analyzes ncfDNA kinetics in children undergoing operations with CPB for congenital heart disease. Elevated preoperative ncfDNA is strongly associated with postoperative arrest and extracorporeal membrane oxygenation. Further studies are needed to validate this technology as a tool to predict morbidity in children after cardiac surgical procedures.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tanem JM, Scott JP, Hoffman GM, et al. Nuclear Cell-Free DNA Predicts Adverse Events After Pediatric Cardiothoracic Surgery. Ann Thorac Surg. 2022. PMID: 36332680. doi:10.1016/j.athoracsur.2022.10.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。